Evidence map›Paper›PMID 32380652›Full record

ArticleMicroorganisms2020

Camila Salazar-Ardiles, Tamara Caimanque, Alexandra Galetović, Claudia Vilo, Jorge E Araya, Nataly Flores, Benito Gómez-Silva

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Camila Salazar-ArdilesLaboratorio de Bioquímica, Departamento Biomédico, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.
Tamara CaimanqueLaboratorio de Bioquímica, Departamento Biomédico, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.ORCID 0000-0003-1740-7387
Alexandra GaletovićLaboratorio de Bioquímica, Departamento Biomédico, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.ORCID 0000-0001-9991-0781
Claudia ViloLaboratorio de Bioquímica, Departamento Biomédico, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.
Jorge E ArayaLaboratorio de Parasitología y Biología Molecular, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.
Nataly FloresLaboratorio de Bioquímica, Departamento Biomédico, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.
Benito Gómez-SilvaLaboratorio de Bioquímica, Departamento Biomédico, and Centre for Biotechnology and Bioengineering, CeBiB, Universidad de Antofagasta, Antofagasta 1270300, Chile.ORCID 0000-0002-7611-9943

Funding

CONICYT CHILE FB-0001UNIVERSIDAD DE ANTOFAGASTA, CHILE 5305
6 · The paper itself

Abstract

In addition to the industrial and biomedical applications of lithium, information on the tolerance of microorganisms to high Li concentrations in natural biological systems is limited. Strain LCHXa is a novel free-living Gram-positive, non-motile bacterium strain isolated from water samples taken at Laguna Chaxa, a non-industrial water body with the highest soluble Li content (33 mM LiCl) within the Salar de Atacama basin in northern Chile. Enrichment was conducted in Luria-Bertani (LB) medium supplemented with 1 M LiCl. Strain LCHXa was a Novobiocin-resistant and coagulase negative

Indexed as

antibiotic susceptibilityAtacama DesertLaguna Chaxalithium toleranceNovobiocin resistanceosmoregulationSalar de AtacamaStaphylococcus sciuri

Identifiers

PMID32380652
PMCPMC7285145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.